Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantation

American Journal of Pathology

Volumn 167, Issue 5, 2005, Pages 1321-1331

  Schimmelpfennig, Christoph H ^a,c   Schulz, Stephan ^a,d   Arber, Caroline ^a   Baker, Jeanette ^a   Tarner, Ingo ^a   McBride, Jacqueline ^a   Contag, Christopher H ^b   Negrin, Robert S ^a,e  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e Center for Clinical Science Building   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD11B ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; FLT3 LIGAND; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 4; LUCIFERASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHYTOHEMAGGLUTININ; RETROVIRUS VECTOR; TUMOR NECROSIS FACTOR ALPHA;

ABDOMEN; ADOPTIVE TRANSFER; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BIOLUMINESCENCE; CELL MIGRATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOTHERAPY; IN VIVO STUDY; LUNG; LYMPHOID ORGAN; MALE; MESENTERY LYMPH NODE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; T LYMPHOCYTE; THYMUS;

EID: 27544508999     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61219-9     Document Type: Article

References (53)

1. Horrowitz M: Uses and growth of hematopoietic cell transplantation. Thomas' Hematopoietic Cell Transplantation. Edited by Thomas ED, Blume KG, Forman SJ, Appelbaum, FR. Maiden, Blackwell Publishers, 2004, pp 9-15
2. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermueller J, de Witte T, Holler E, Ansari H: Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995, 86:2041-2050
3. Kolb HJ, Holler E: Adoptive immunotherapy with donor lymphocyte transfusions. Curr Opin Oncol 1997, 9:139-145
4. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991, 9:271-296
5. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K: Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811
6. Steinman RM, Nussenzweig MC: Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 2002, 99:351-358
7. Jonuleit H, Schmitt E, Steinbrink K, Enk AH: Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 2001, 22:394-400
8. Moser M: Dendritic cells. Fundamental Immunology. Edited by Paul WE. Philadelphia, Lippincott Williams & Wilkins, 2003, pp 455-480
9. O'Neill DW, Adams S, Bhardwaj N: Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood 2004, 104:2235-2246
10. Schuler G, Schuler-Thurner B, Steinman RM: The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 2003, 15:138-147
11. Stift A, Friedl J, Dubsky P, Bachleitner-Hofmann T, Schueller G, Zontsich T, Benkoe T, Radelbauer K, Brostjan C, Jakesz R, Gnant M: Dendritic cell-based vaccination in solid cancer. J Clin Oncol 2003, 21:135-142
12. Ridgway D: The first 1000 dendritic cell vaccinees. Cancer Invest 2003, 21:873-886
13. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH: Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000, 192:1213-1222
14. O'Connell PJ, Li W, Wang Z, Specht SM, Logar AJ, Thomson AW: Immature and mature CD8{alpha}+ dendritic cells prolong the survival of vascularized heart allografts. J Immunol 2002, 168:143-154
15. Giannoukakis N, Bonham CA, Qian S, Zhou Z, Peng L, Harnaha J, Li W, Thomson AW, Fung JJ, Robbins PD, Lu L: Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides. Mol Ther 2000, 1:430-437
16. Bonham CA, Peng L, Liang X, Chen Z, Wang L, Ma L, Hackstein H, Robbins PD, Thomson AW, Fung JJ, Qian S, Lu L: Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J Immunol 2002, 169:3382-3391
17. Fu F, Li Y, Qian S, Lu L, Chambers F, Starzl TE, Fung JJ, Thomson AW: Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996, 62:659-665
18. Fearnley DB, Whyte LF, Carnoutsos SA, Cook AH, Hart DNJ: Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation. Blood 1999, 93:728-736
19. Traver D, Akashi K, Manz M, Merad M, Miyamoto T, Engleman EG, Weissman IL: Development of CD8alpha-positive dendritic cells from a common myeloid progenitor. Science 2000, 290:2152-2154
20. Leon B, Martinez del Hoyo G, Parrillas V, Hernandez Vargas H, Sanchez-Mateos P, Longo N, Lopez-Bravo M, Ardavin C: Dendritic cell differentiation potential of mouse monocytes: monocytes represent immediate precursors of CD8- and CD8+ splenic dendritic cells. Blood 2004, 103:2001-0286
21. Edinger M, Cao YA, Verneris MR, Bachmann MH, Contag CH, Negrin RS: Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 2003, 101:640-648
22. Beilhack A, Schulz S, Baker J, Beilhack GF, Wieland CB, Herman EI, Baker EM, Cao YA, Contag CH, Negrin RS: In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T cell subsets. Blood 2005, 106:1113-1122
23. Caux C, Ait-Yahia S, Chemin K, de Bouteiller O, Dieu-Nosjean MC, Homey B, Massacrier C, Vanbervliet B, Zlotnik A, Vicari A: Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin Immunopathol 2000, 22:345-369
24. Martin-Fontecha A, Sebastiani S, Hopken UE, Uguccioni M, Lipp M, Lanzavecchia A, Sallusto F: Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med 2003, 198:615-621
25. Colvin BL, Morelli AE, Logar AJ, Lau AH, Thomson AW: Comparative evaluation of CC chemokine-induced migration of murine CD8alpha+ and CD8alpha- dendritic cells and their in vivo trafficking. J Leukoc Biol 2004, 75:275-285
26. Serafini B, Columba-Cabezas S, Di Rosa F, Aloisi F: Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am J Pathol 2000, 157:1991-2002
27. Middel P, Thelen P, Blaschke S, Polzien F, Reich K, Blaschke V, Wrede A, Hummel KM, Gunawan B, Radzun HJ: Expression of the T-cell chemoattractant chemokine lymphotactin in Crohn's disease. Am J Pathol 2001, 159:1751-1761
28. Higuchi M, Zeng D, Shizuru J, Gworek J, Dejbakhsh-Jones S, Taniguchi M, Strober S: Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion. J Immunol 2002, 169:5564-5570
29. Takayama T, Tahara H, Thomson AW: Transduction of dendritic cell progenitors with a retroviral vector encoding viral interleukin-10 and enhanced green fluorescent protein allows purification of potentially tolerogenic antigen-presenting cells. Transplantation 1999, 68:1903-1909
30. Pear WS, Nolan GP, Scott ML, Baltimore D: Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 1993, 90:8392-8396
31. Costa GL, Benson JM, Seroogy CM, Achacoso P, Fathman CG, Nolan GP: Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease. J Immunol 2000, 164:3581-3590
32. Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S, Negrin RS: CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 2003, 9:1144-1150
33. Cook EB, Stahl JL, Lowe L, Chen R, Morgan E, Wilson J, Varro R, Chan A, Graziano FM, Barney NP: Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergies vs. non-allergies. J Immunol Methods 2001, 254:109-118
34. Khanna A, Plummer M, Bromberek K, Woodliff J, Hariharan S: Immunomodulation in stable renal transplant recipients with concomitant tacrolimus and sirolimus therapy. Med Immunol 2002, 1:3
35. Rice BW, Cable MD, Nelson MB: In vivo imaging of light-emitting probes. J Biomed Opt 2001, 6:432-440
36. Jockusch H, Voigt S, Eberhard D: Localization of GFP in frozen sections from unfixed mouse tissues: immobilization of a highly soluble marker protein by formaldehyde vapor. J Histochem Cytochem 2003, 51:401-404
37. Mandl S, Schimmelpfennig C, Edinger M, Negrin RS, Contag CH: Understanding immune cell trafficking patterns via in vivo bioluminescence imaging. J Cell Biochem Suppl 2002, 39:239-248
38. Edinger M, Cao YA, Hornig YS, Jenkins DE, Verneris MR, Bachmann MH, Negrin RS, Contag CH: Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur J Cancer 2002, 38:2128-2136
39. Sweeney TJ, Mailander V, Tucker AA, Olomu AB, Zhang W, Cao Y, Negrin RS, Contag CH: Visualizing the kinetics of tumor-cell clearance in living animals. Proc Natl Acad Sci USA 1999, 96:12044-12049
40. Edinger M, Sweeney TJ, Tucker AA, Olomu AB, Negrin RS, Contag CH: Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia 1999, 1:303-310
41. Fehr T, Sykes M: Tolerance induction in clinical transplantation. Transpl Immunol 2004, 13:117-130
42. Claas F: Chimerism as a tool to induce clinical transplantation tolerance. Curr Opin Immunol 2004, 16:578-583
43. Kamath AT, Henri S, Battye F, Tough DF, Shortman K: Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 2002, 100:1734-1741
44. Kamath AT, Pooley J, O'Keeffe MA, Vremec D, Zhan Y, Lew AM, D'Amico A, Wu L, Tough DF, Shortman K: The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J Immunol 2000, 165:6762-6770
45. Garg S, Oran A, Wajchman J, Sasaki S, Maris CH, Kapp JA, Jacob J: Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo. Nat Immunol 2003, 4:907-912
46. Hon H, Rucker III EB, Hennighausen L, Jacob J: bcl-xL is critical for dendritic cell survival in vivo. J Immunol 2004, 173: 4425-4432
47. Rastellini C, Lu L, Ricordi C, Starzl TE, Rao AS, Thomson AW: Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995, 60:1366-1370
48. Zhang W, Tang H, Quo Z, An H, Zhu X, Song W, Quo J, Huang X, Chen T, Wang J, Cao X: Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat Immunol 2004, 5:1124-1133
49. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J, Shlomchik MJ, Emerson SG: Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999, 285:412-415
50. Zhang Y, Shlomchik WD, Joe G, Louboutin J-P, Zhu J, Rivera A, Giannola D, Emerson SG: APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease. J Immunol 2002, 169:7111-7118
51. Merad M, Hoffmann P, Ranheim E, Slaymaker S, Manz MG, Lira SA, Charo I, Cook DN, Weissman IL, Strober S, Engleman EG: Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat Med 2004, 10:510-517
52. Sato K, Yamashita N, Baba M, Matsuyama T: Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 2003, 18:367-379
53. Matte CC, Liu J, Cormier J, Anderson BE, Athanasiadis I, Jain D, McNiff J, Shlomchik WD: Donor APCs are required for maximal GVHD but not for GVL. Nat Med 2004, 10:987-992